All news


UK competition regulator opens inquiry of Aviva buy of Direct Line

The UK competition regulator on Wednesday opened a probe into the acquisition of Direct Line Insurance Group PLC by larger peer Aviva PLC

The motor and...

Wed, 14/05/2025 - 10:06


Coca-Cola Europacific Partners backs medium-term outlook

Coca-Cola Europacific Partners PLC on Wednesday maintained its medium-term financial objectives, ahead of a capital markets event.

The soft drink bottler re-affirmed mid-term growth objectives,...

Wed, 14/05/2025 - 10:06


Burberry to cut 1,700 jobs but optimistic that ‘best days are ahead’

Burberry Group PLC on Wednesday announced new cost-cutting measures after reporting lower annual sales as its strategic reset continues.

The London-based luxury goods manufacturer reported a...

Wed, 14/05/2025 - 09:58


Persimmon announces sale of FibreNest for around £100 million

Persimmon PLC on Wednesday said it will sell its full fibre broadband service FibreNest to BUUK Infrastructure.

The York, England-based housebuilder said the discounted total enterprise...

Wed, 14/05/2025 - 09:57


Spirax maintains annual guidance but tariff impact still ‘uncertain’

Spirax Group PLC on Wednesday said it delivered low single-digit organic revenue growth so far this year, and maintains its outlook for the whole of...

Wed, 14/05/2025 - 09:56


Imperial Brands CEO Stefan Bomhard to step down amid mixed first-half

Imperial Brands PLC on Wednesday said Chief Executive Stefan Bomhard will retire this year as it reported a drop in half-year sales.

The Bristol, England-based tobacco...

Wed, 14/05/2025 - 09:38


LONDON BROKER RATINGS: RBC cuts AB Foods; JPMorgan raises Mondi

The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

----------

FTSE 100

----------

Jefferies raises IMI price target to 2,340 (2,315) pence - ’buy’

----------

JPMorgan raises...

Wed, 14/05/2025 - 09:30


Experian ups dividend as annual profit flat; confident in outlook

Experian PLC on Wednesday said it has a resilient portfolio and a ‘strong record of growth’, citing confidence for the newly started financial year as...

Wed, 14/05/2025 - 09:23


GSK acquires ‘potential best-in-class’ medicine efimosfermin

GSK announced on Wednesday that it has agreed with Boston Pharmaceuticals to buy steatotic liver disease medication efimosfermin alfa.

The London-based pharmaceutical company said efimosfermin, Boston...

Wed, 14/05/2025 - 09:13


Early market roundup: London outperforms peers while gold price falls

The London blue chip index outperformed its peers in Paris and Frankfurt on Wednesday morning, despite shares in FTSE 100 constituent Imperial Brands falling as...

Wed, 14/05/2025 - 09:05


Pages